{"id": "346495", "url": "https://fevir.net/resources/EvidenceVariable/346495", "meta": {"versionId": "5", "lastUpdated": "2026-01-26T16:43:36.602Z"}, "name": "CTIS2024_516402_32_00_Secondary_Outcome_8", "title": "CTIS2024-516402-32-00 Secondary Outcome 8", "author": [{"name": "Brian S. Alper, MD, MSPH"}], "citeAs": "CTIS2024-516402-32-00 Secondary Outcome 8 [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 346495. Revised 2026-01-26. Available at: https://fevir.net/resources/EvidenceVariable/346495. Computable resource at: https://fevir.net/resources/EvidenceVariable/346495#json.", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "publisher": "Computable Publishing LLC", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "346495", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "value": "CTIS2024-516402-32-00 Secondary Outcome 8", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "CTIS endPoint id"}, "value": "441516"}], "description": "Costs relating to renal replacement therapy (or lack of), Eculizumab and other antihypertensive treatments, hospitalizations", "resourceType": "EvidenceVariable"}